090940/WT_/Wellcome Trust/United Kingdom[Grants and Funding] - Search Results

Year	Number of Results
2010	2
2011	10
2012	3
2013	6
2014	6
2015	1
2019	1
2024	0

1

Interactions between HIV-1 and the cell-autonomous innate immune system.

Towers GJ, Noursadeghi M. Towers GJ, et al. Cell Host Microbe. 2014 Jul 9;16(1):10-8. doi: 10.1016/j.chom.2014.06.009. Cell Host Microbe. 2014. PMID: 25011104 Free PMC article. Review.

2

Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.

Chan E, Towers GJ, Qasim W. Chan E, et al. Viruses. 2014 Jan 14;6(1):243-63. doi: 10.3390/v6010243. Viruses. 2014. PMID: 24424502 Free PMC article. Review.

3

A model for cofactor use during HIV-1 reverse transcription and nuclear entry.

Hilditch L, Towers GJ. Hilditch L, et al. Curr Opin Virol. 2014 Feb;4(100):32-6. doi: 10.1016/j.coviro.2013.11.003. Epub 2014 Jan 14. Curr Opin Virol. 2014. PMID: 24525292 Free PMC article. Review.

4

Inhibition of retroviral replication by members of the TRIM protein family.

Fletcher AJ, Towers GJ. Fletcher AJ, et al. Curr Top Microbiol Immunol. 2013;371:29-66. doi: 10.1007/978-3-642-37765-5_2. Curr Top Microbiol Immunol. 2013. PMID: 23686231 Review.

5

Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice.

Skelton JK, Ortega-Prieto AM, Kaye S, Jimenez-Guardeño JM, Turner J, Malim MH, Towers GJ, Dorner M. Skelton JK, et al. J Virol. 2019 May 15;93(11):e02123-18. doi: 10.1128/JVI.02123-18. Print 2019 Jun 1. J Virol. 2019. PMID: 30867315 Free PMC article.

6

HIV-1 evades innate immune recognition through specific cofactor recruitment.

Rasaiyaah J, Tan CP, Fletcher AJ, Price AJ, Blondeau C, Hilditch L, Jacques DA, Selwood DL, James LC, Noursadeghi M, Towers GJ. Rasaiyaah J, et al. Nature. 2013 Nov 21;503(7476):402-405. doi: 10.1038/nature12769. Epub 2013 Nov 6. Nature. 2013. PMID: 24196705 Free PMC article.

7

Disease-associated XMRV sequences are consistent with laboratory contamination.

Hué S, Gray ER, Gall A, Katzourakis A, Tan CP, Houldcroft CJ, McLaren S, Pillay D, Futreal A, Garson JA, Pybus OG, Kellam P, Towers GJ. Hué S, et al. Retrovirology. 2010 Dec 20;7(1):111. doi: 10.1186/1742-4690-7-111. Retrovirology. 2010. PMID: 21171979 Free PMC article.

8

HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.

Sauter D, Hué S, Petit SJ, Plantier JC, Towers GJ, Kirchhoff F, Gupta RK. Sauter D, et al. Retrovirology. 2011 Dec 15;8:103. doi: 10.1186/1742-4690-8-103. Retrovirology. 2011. PMID: 22171785 Free PMC article.

9

SAMHD1-dependent retroviral control and escape in mice.

Rehwinkel J, Maelfait J, Bridgeman A, Rigby R, Hayward B, Liberatore RA, Bieniasz PD, Towers GJ, Moita LF, Crow YJ, Bonthron DT, Reis e Sousa C. Rehwinkel J, et al. EMBO J. 2013 Sep 11;32(18):2454-62. doi: 10.1038/emboj.2013.163. Epub 2013 Jul 19. EMBO J. 2013. PMID: 23872947 Free PMC article.

10

TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.

Di Pietro A, Kajaste-Rudnitski A, Oteiza A, Nicora L, Towers GJ, Mechti N, Vicenzi E. Di Pietro A, et al. J Virol. 2013 Apr;87(8):4523-33. doi: 10.1128/JVI.02548-12. Epub 2013 Feb 13. J Virol. 2013. PMID: 23408607 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year